Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Research facility
Location:
Mexico City,
Mexico (MX)
ISNI: 0000000106984037
ROR: https://ror.org/00xgvev73
Show on Map:
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis (2021)
Efe C, Lammert C, Tascilar K, Dhanasekaran R, Ebik B, Higuera-De La Tijera F, Caliskan AR, et al.
Journal article
Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease (2021)
McMurray JJ, Wheeler DC, Stefánsson BV, Jongs N, Postmus D, Correa-Rotter R, Chertow GM, et al.
Journal article
Dapagliflozin in Patients with Chronic Kidney Disease (2020)
Heerspink HJL, Stefansson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann J, et al.
Journal article
Epidemiology, molecular, and genetic methodologies to evaluate causes of CKDu around the world: report of the Working Group from the ISN International Consortium of Collaborators on CKDu (2019)
Anand S, Caplin B, Gonzalez-Quiroz M, Schensul SL, Bhalla V, Parada X, Nanayakkara N, et al.
Journal article, Editorial